Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Alzamend Neuro Inc’s stock clocked out at $1.82, down -5.21% from its previous closing price of $1.92. In other words, the price has decreased by -$5.21 from its previous closing price. On the day, 0.19 million shares were traded. ALZN stock price reached its highest trading level at $1.94 during the session, while it also had its lowest trading level at $1.6905.
Ratios:
To gain a deeper understanding of ALZN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.58 and its Current Ratio is at 6.58. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
. In the most recent recommendation for this company, Ascendiant Capital Markets on October 01, 2021, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 23 ’25 when AULT MILTON C III sold 1,851 shares for $2.07 per share. The transaction valued at 3,825 led to the insider holds 0 shares of the business.
Horne William B. sold 3,333 shares of ALZN for $7,059 on Dec 19 ’25. The Director now owns 0 shares after completing the transaction at $2.12 per share. On Oct 23 ’25, another insider, McGrath Lynne Fahey, who serves as the Director of the company, sold 30 shares for $2.29 each. As a result, the insider received 69 and left with 25 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALZN now has a Market Capitalization of 6918921 and an Enterprise Value of 2469486.
Stock Price History:
The Beta on a monthly basis for ALZN is -0.25, which has changed by -0.82222223 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, ALZN has reached a high of $11.70, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is -18.67%, while the 200-Day Moving Average is calculated to be -48.65%.
Shares Statistics:
It appears that ALZN traded 104.17K shares on average per day over the past three months and 49850 shares per day over the past ten days. A total of 3.80M shares are outstanding, with a floating share count of 3.69M. Insiders hold about 2.83% of the company’s shares, while institutions hold 3.88% stake in the company. Shares short for ALZN as of 1765756800 were 264718 with a Short Ratio of 2.54, compared to 1763078400 on 196244. Therefore, it implies a Short% of Shares Outstanding of 264718 and a Short% of Float of 9.32.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.67 and low estimates of -$0.67. Analysts are recommending an EPS of between -$2.52 and -$2.52 for the fiscal current year, implying an average EPS of -$2.52. EPS for the following year is -$2.98, with 2.0 analysts recommending between -$2.6 and -$3.37.
